Apply to Be the Next EIC of Molecular Therapy Methods & Clinical Development

ASGCT is looking for the next editor-in-chief of Molecular Therapy Methods & Clinical Development (MTMCD) to begin a five-year term on Jan. 1, 2024.

MTMCD is an international, open-access journal publishing important peer-reviewed advances in cell and gene therapy and how they are translated and applied in the clinical setting. Its 2021 impact factor is 5.849. The current editor, Gerhard Bauer, PhD, will step down Dec. 31, 2023.

Read more about the position's responsibilities here. If you're interested in applying, please send a letter of intent detailing your relevant experience and vision for the journal as well as a current CV to ASGCT CEO David Barrett.

Read the position description & Apply

Related Articles